ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Yönetim Kurulu Komiteleri 17 Mart 2026

At the meeting of the Board of Directors of our Company held on 17.03.2026;

In accordance with the provisions of the Corporate Governance Communiqué (II-17.1) of the Capital Markets Board and within the framework of the Corporate Governance Principles and the working procedures of the committees;

 
•  

  Ms. Derya Kara was elected as the Chairperson of the Audit Committee, and Ms. Zerrin Çavuşoğlu as member,

   
 
•  

  Ms. Derya Kara was elected as the Chairperson of the Early Detection of Risk Committee, and Ms. Fatma Çelik as member,

   
 
•  

  Ms. Burçin Budakoğlu was elected as the Chairperson of the Corporate Governance Committee, and Ms. Tevhide Sarıtaş and Mr. Birol Erol as members,

   
 

and furthermore, in accordance with the Corporate Governance Communiqué (II-17.1) of the Capital Markets Board, it was resolved that the duties and responsibilities of the Nomination Committee and the Remuneration Committee shall be fulfilled by the Corporate Governance Committee.

The above resolutions were adopted unanimously by the members present.

Respectfully announced to the public.

The English translation of this disclosure is provided in the attachment. In case of any discrepancy between the Turkish and English versions of the disclosure texts, the Turkish version shall prevail.